MedTrace Logo

Family Promoting Positive Emotions Pilot Study

NCT05223842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2023-02-01

No results posted yet for this study

Summary

Anhedonia is characterized by loss of interest or pleasure. The proposed pilot study would be the first to test an innovative, neuroscience-informed intervention in mothers reporting depressive symptoms and stress to enhance positive emotionality with the goal of preventing anhedonia and associated emotional disturbances in their children. This study will recruit dyads (mothers and their children) for the intervention.

Conditions

  • Depression
  • Anhedonia
  • Stress
  • Depressive Disorder
  • Behavioral Symptoms
  • Mood Disorders
  • Mental Disorder
  • Mood Disturbance

Interventions

BEHAVIORAL

Family Promoting Positive Emotions (F-PPE)

F-PPE is an 8-session dyadic intervention designed to enhance positive emotionality and buffer against the effects of stress on anhedonia in children. The intervention will be administered online through videoconferencing sessions with a clinician to mothers and their children.

BEHAVIORAL

Written Information

Mothers assigned to the Written Information condition will receive email newsletters providing resources relevant to depression.

Sponsors & Collaborators

  • American Psychological Foundation

    collaborator OTHER

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Autumn J Kujawa, PhD · Vanderbilt University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05223842 on ClinicalTrials.gov